Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Raises Low End Of Prior FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance


Tuesday, 6 Aug 2013 07:00am EDT 

Endo Health Solutions Inc announced that for fiscal 2013, it expects total revenue to be between $2.70 billion and $2.80 billion, reported (GAAP) diluted earnings per share to be between $1.47 and $1.77 and adjusted diluted earnings per share (EPS) to be between $4.25 and $4.55. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $2.74 billion and EPS of $4.32 for fiscal 2013. 

Company Quote

64.46
-0.25 -0.39%
12 Sep 2014